ADORA2A and Parkinson disease: [18F]FESCH has been evaluated in healthy rats and in rats with unilateral PD symptoms by PET showing an A2AR-specific binding in the striatum and a significantly increased A2AR-mediated uptake in the 6-hydroxydopamine-lesioned hemisphere of 9–12% [19,21].